Most Popular Stories
- New contenders will duke it out with Vertex for the hep C crown
- Biotech spin-out grabs $76M in venture cash for antibiotic work
- Mylan snags Pfizer's Advair copy, inhaler technology
- Pharmacies accuse Pfizer, Ranbaxy of secret Lipitor deal
- Bavarian Nordic sees positive results in small therapeutic cancer vax study
- Class-action securities suit goes forward against Amgen
Featured Jobs
-
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US -
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US -
Associate Director, Global Production Planning & Inventory Control Job
Celgene Corporation - Basking Ridge, NJ, US -
Scientist/Sr. Scientist, Bio-analytical Chemistry
Dicerna Pharmaceuticals, Inc. - Watertown, MA -
Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY
More Jobs >>
Events
- New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA - CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami - Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA - Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
More Events >>
Biography for Erica Teichert
Erica Teichert is the associate editor of the FierceBiotech and FiercePharma publications. A San Francisco native, Erica previously interned for the Deseret News (Utah), Where Magazine (Washington, D.C.) and BYU Magazine (Utah). She has a passion for travel, ancient history and NBA basketball-especially the Cleveland Cavaliers and Utah Jazz. She is based at the FierceMarkets main office in Washington, D.C., and can be reached at [email protected]. Follow @FierceMedDev on Twitter and find her on LinkedIn.
Articles by Erica Teichert
- March 25, 2011
- OSU starts anti-cancer vax trial; Gates compares Microsoft to vax philanthropy;March 24, 2011
- Promising protein may yield TB vaxMarch 23, 2011
- March 23, 2011
- March 17, 2011
- March 16, 2011
- GSK's hep A/B vax stays effective for a decade; Drop in ear infections could be due to vaccines;March 9, 2011
- March 9, 2011
- March 3, 2011
- Inovio gets good news against foot-and-mouth diseaseMarch 2, 2011
- February 24, 2011
- February 24, 2011
- Stemline licences brain cancer vax; Boston employees receive measles vax to stem outbreak;February 23, 2011
- February 23, 2011
- February 11, 2011
- February 10, 2011
- February 9, 2011
- Inovio positive DNA vax results publishedFebruary 2, 2011
- January 26, 2011
- January 20, 2011
- January 12, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
